If you have liver cirrhosis or chronic hepatitis B infection, you may qualify to participate in a research study that compares the effectiveness of two liver cancer screening methods. Please contact the study team to get more information. Compensation provided.

We are studying an investigational drug, Efruxifermin, to see if it will help in the treatment of liver inflammation and scarring (fibrosis) in adults diagnosed with Compensated Cirrhosis due to NASH (non-alcoholic steatohepatitis) and MASH (metabolic dysfunction-associated steatohepatitis).

Do you have With Locally Advanced or Metastatic Solid Tumors of the Head or Neck? If so, you may be able to participate in a research study to to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of INBRX 106 administered as a single agent or in combination with the anti-PD-1 checkpoint inhibitor (CPI) pembrolizumab (Keytruda®).

Preventing walking disability in our rapidly aging population is an enormous public health challenge. Fundamental to their loss of functional mobility is that the muscles needed to power walking experience disproportionate declines in function with age. Wearable assistive devices can be designed to augment the function of these muscles and may make walking easier. If you are a healthy young adult, you may be eligible to participate in a study to help guide the development of more effective exoskeleton designs!

In this study, we want to see how patients with metastatic non-small cell lung cancer do with two treatments: ivonescimab and chemotherapy. We are comparing these treatments to find out which one helps patients more.

Do you have non small cell lung cancer? Are you currently not on any other treatments for your cancer? If you answered yes, you may be able to take part in a lung cancer medication study.

In this study, we want to learn more about how common online sexual harassment is. Our goal is to better understand it and find better ways to measure it in research.

In this study, we want to test a new web application we are creating. The app will help users find important information about digital health resources and how ready a community is to use them.

To conduct a pilot trial to determine feasibility and acceptability of the refined PREVAIL model in at least 50 adults with rheumatoid arthritis.

Have you given birth in the past 12 months? Have you been feeling down or noticed any changes since then? If so, you may be able to participate in a study to see if a new medication can reduce symptoms of depression after childbirth, also known as postpartum depression. Compensation provided.